Falsely raised serum thyrotropin with modified immunoradiometric assay

Liver volume, portal vein flow, and clearance of indocyanine green and antipyrine in hyperthyroidism before and after antithyroid treatment.

Scandinavian journal of gastroenterology·1999

[False results on elevated triiodothyronine values in radioimmunoassay].

Ugeskrift for laeger·1995

The thyroid function and size in healthy man during 3 weeks treatment with beta-adrenoceptor-antagonists.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·1991

Acute beta-blockade changes the extracellular distribution of thyroid hormones.

Journal of endocrinological investigation·1990

Differential effect of continuous administration of beta-adrenoceptor antagonists on antipyrine and phenytoin clearance.

British journal of clinical pharmacology·1989

Short-term beta-adrenergic blockade decreases serum thyroglobulin in hyper- and euthyroid patients.

Journal of endocrinological investigation·1986

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Integrated peripheral immune profiling reveals B-cell dysregulation and CD8 effector signatures in chronic inflammatory demyelinating polyneuropathy.

Frontiers in immunology·2026

An iguratimod prodrug reduces RA-FLS invasiveness by disrupting STAT1-C3-TNFα-mediated crosstalk between fibroblast-like synoviocytes and macrophages.

Journal of orthopaedic translation·2026

Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistry.

Frontiers in pharmacology·2026

Primary adrenal epithelioid angiosarcoma: An extraordinarily rare malignancy with a challenging diagnosis.

Radiology case reports·2026

Nodal metastasis from an occult duodenal gastrinoma amid an overlap of xanthogranulomatous and type 1 autoimmune pancreatitis: A case report.

Radiology case reports·2026

Utility of monocyte-derived cells to investigate immune-mediated drug-induced liver injury.

Toxicology letters·2026

Related Experiment Videos

Falsely raised serum thyrotropin with modified immunoradiometric assay

Related Concept Videos

Liver volume, portal vein flow, and clearance of indocyanine green and antipyrine in hyperthyroidism before and after antithyroid treatment.

[False results on elevated triiodothyronine values in radioimmunoassay].

The thyroid function and size in healthy man during 3 weeks treatment with beta-adrenoceptor-antagonists.

Acute beta-blockade changes the extracellular distribution of thyroid hormones.

Differential effect of continuous administration of beta-adrenoceptor antagonists on antipyrine and phenytoin clearance.

Short-term beta-adrenergic blockade decreases serum thyroglobulin in hyper- and euthyroid patients.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Integrated peripheral immune profiling reveals B-cell dysregulation and CD8 effector signatures in chronic inflammatory demyelinating polyneuropathy.

An iguratimod prodrug reduces RA-FLS invasiveness by disrupting STAT1-C3-TNFα-mediated crosstalk between fibroblast-like synoviocytes and macrophages.

Interleukin-17 in disease pathogenesis and therapy: recent advances in targeted drug design and medicinal chemistry.

Primary adrenal epithelioid angiosarcoma: An extraordinarily rare malignancy with a challenging diagnosis.

Nodal metastasis from an occult duodenal gastrinoma amid an overlap of xanthogranulomatous and type 1 autoimmune pancreatitis: A case report.

Utility of monocyte-derived cells to investigate immune-mediated drug-induced liver injury.

Related Experiment Videos

Falsely raised serum thyrotropin with modified immunoradiometric assay

Related Concept Videos

Related Articles